COVID-19 Omicron (Bivalent) Vaccines: Transitioning to a Simpler Schedule for All Ages

Price $4.00

Credits 1

Format

This program provides a comprehensive review of the latest CDC recommendations for the transition to bivalent mRNA vaccines and the clinical considerations for all ages. Specifically addressed are doses needed to stay up-to-date for those over 65 years and the immunocompromised.

$4.00

OR

Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience

Pharmacy Technician

Nurse Practitioner

Pharmacist

Nurse

Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

Pharmacy Technician

Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines.
Identify the appropriate Center's for Disease Control (CDC) COVID-19 vaccine recommendations for the Omicron bivalent Pfizer and Moderna vaccine for ages 6 months and older.
Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent vaccines recommendations for moderate to severely immunocompromised.
Identify adverse events with the COVID-19 Omicron bivalent booster.

Nurse Practitioner

Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines.
Identify the appropriate Center's for Disease Control (CDC) COVID-19 vaccine recommendations for the Omicron bivalent Pfizer and Moderna vaccine for ages 6 months and older.
Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent vaccines recommendations for moderate to severely immunocompromised.
Identify adverse events with the COVID-19 Omicron bivalent booster.

Pharmacist

Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines.
Identify the appropriate Center's for Disease Control (CDC) COVID-19 vaccine recommendations for the Omicron bivalent Pfizer and Moderna vaccine for ages 6 months and older.
Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent vaccines recommendations for moderate to severely immunocompromised.
Identify adverse events with the COVID-19 Omicron bivalent booster.

Nurse

Describe the mechanism of action of the omicron bivalent authorized COVID-19 vaccines.
Identify the appropriate Center's for Disease Control (CDC) COVID-19 vaccine recommendations for the Omicron bivalent Pfizer and Moderna vaccine for ages 6 months and older.
Recognize appropriate recommendations for CDC COVID-19 Omicron bivalent vaccines recommendations for moderate to severely immunocompromised.
Identify adverse events with the COVID-19 Omicron bivalent booster.

Course Accreditation

Activity Type:
CE Broker
1041178
Universal Activity Number:
Pharmacy Technician : 0798-0000-23-156-H06-T
Nurse : 0798-0000-23-156-H06-N
Pharmacist : 0798-0000-23-156-H06-P

PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

In order to obtain a Statement of Credit, attendees must answer poll questions where presented and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.

Technology Requirements

Hardware Requirements
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones

Software Requirements
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones

Network Requirements
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection

Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.